| Literature DB >> 31198660 |
Cheryl Modica1, Joy H Lewis2, Curt Bay3.
Abstract
BACKGROUND: Colorectal cancer is the second leading cause of cancer death in the U.S. and third-most common cancer in both men and women. Colorectal cancer screening (CRCS) rates remain low, particularly among vulnerable patients receiving care at federally qualified health centers. Through its Value Transformation Framework, the National Association of Community Health Centers provides a systematic approach to improving CRCS by transforming health center infrastructure, care delivery, and people systems-to improve health outcomes, patient and staff experiences, and lower costs (Quadruple Aim).Entities:
Keywords: Colorectal Cancer; Evidence-base; Health centers; Quadruple Aim; Quality Improvement; Screening; Transformation
Year: 2019 PMID: 31198660 PMCID: PMC6556543 DOI: 10.1016/j.pmedr.2019.100894
Source DB: PubMed Journal: Prev Med Rep ISSN: 2211-3355
Fig. 1Value Transformation Framework.
Profile of the 8 participating health centers (6 urban, 2 rural).
| 2016 UDS (uniform data systems) data element | Average | Range |
|---|---|---|
| Number of patient visits | 17,496 | 2500–38,000 |
| % Racial/ethnic minorities | 49% | 5%–77% |
| % Best served in another language | 11% | <1%–25% |
| % Uninsured | 30% | 5%–54% |
| Baseline colorectal cancer screening | 39% | 31%–56% |
Organizational-level UDS data rounded to the nearly whole % or hundreds.
Number of months each intervention was in place by site.
| Health center intervention site | ||||||||
|---|---|---|---|---|---|---|---|---|
| Type of year 1 intervention | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 1. Written policy for CRCS (formal/approved) | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 12 |
| 2. Written procedure/graphic workflow for CRCS | 12 | 1 | 1 | 1 | 11 | 4 | 8 | 12 |
| 3. Standing orders for CRCS | 12 | 12 | 2 | 0 | 0 | 0 | 0 | 12 |
| 4. Clinical champion for CRCS | 12 | 5 | 0 | 10 | 11 | 0 | 0 | 0 |
| 5. Patient outreach/recall for CRCS | 12 | 7 | 8 | 8 | 1 | 12 | 4 | 12 |
| 6. Patient incentive for CRCS | 0 | 5 | 0 | 8 | 10 | 12 | 8 | 0 |
| 7. Performance data shared at provider/team-level | 12 | 12 | 0 | 0 | 1 | 12 | 12 | 12 |
| 8. Performance data shared at site/health center- level | 12 | 12 | 12 | 12 | 5 | 12 | 12 | 12 |
| 9. Provider alert in EHR that CRCS needed | 12 | 12 | 12 | 5 | 12 | 12 | 12 | 12 |
| 10. Pre-visit chart review for CRCS | 12 | 9 | 8 | 5 | 0 | 12 | 12 | 12 |
| Mean # Interventions over 12 months | 9.2 | 6.8 | 3.8 | 4.6 | 3.5 | 6.3 | 5.5 | 9.2 |
Abbreviations: CRCS: colorectal cancer screening; EHR: electronic health record;
FOBT/FIT: fecal occult blood testing/fecal immunochemical test.
Monthly colorectal cancer screening reporting using Uniform Data System (UDS) instructions. Source: https://bphc.hrsa.gov/sites/default/files/bphc/datareporting/reporting/2017udsreportingmanual.pdf
| Measure | Measure definition | Numerator | Denominator |
|---|---|---|---|
| Colorectal cancer screening | The percentage of patients ages 50–75 years with the appropriate screening for colorectal cancer. | Number of patients with a documented CRCS based on the following criteria: Colonoscopy during the past 10 years OR | Number of patients 51–75 years who had at least one medical visit during the past month. Excludes patients with a diagnosis of colorectal cancer or evidence of colectomy. |
Percent of patients up-to-date with CRCS for each health center, Georgia and Iowa, during January 2017, December 2017, and the 12-month intervention period.
| Health center site | January 2017 | December 2017 | 12 Months |
|---|---|---|---|
| 1 | 61.7% | 81.5% | 70.2% |
| 2 | 35.6% | 51.9% | 40.8% |
| 3 | 29.2% | 52.7% | 37.0% |
| 4 | 15.6% | 45.8% | 23.5% |
| 35.6% | 58.0% | 42.9% | |
| 5 | 33.0% | 50.0% | 42.2% |
| 6 | 39.9% | 46.6% | 40.2% |
| 7 | 37.1% | 37.7% | 38.4% |
| 8 | 13.5% | 14.2% | 15.0% |
| 30.9% | 37.1% | 34.0% | |
Fig. 2Percent of patients up-to-date with CRCS for each month and each health center site.
Census-weighted means (95% CI) for percent of eligible patients up-to-date with CRCS guidelines when interventions absent and present.
| Intervention | Absent | Present | |
|---|---|---|---|
| 1. Written policy for CRCS (formal/approved) | 40.8 (32.3, 51.5) | 31.1 (22.4, 43.2) | 0.049 |
| 2. Written procedure/graphic workflow for CRCS | 36.2 (27.3, 48.2) | 41.2 (32.1, 52.9) | 0.121 |
| 3. Standing orders for CRCS | 36.5 (30.2, 44.2) | 43.4 (31.6, 59.6) | 0.026 |
| 4. Clinical champion for CRCS | 39.2 (30.4, 50.6) | 39.7 (29.8, 52.9) | 0.814 |
| 5. Patient outreach/recall for CRCS | 37.9 (29.1, 49.5) | 40.4 (31.2, 52.3) | 0.180 |
| 6. Patient incentive for CRCS | 38.5 (28.6, 51.8) | 40.7 (31.7, 52.3) | 0.412 |
| 7. Performance data shared at provider/team-level | 38.5 (30.1, 48.1) | 39.9 (30.1, 52.9) | 0.534 |
| 8. Performance data shared at site and/or organization level | 35.2 (27.6, 45.0) | 39.8 (30.5, 51.8) | <0.0001 |
| 9. Provider alert in EHR that CRCS is needed | 31.7 (25.1, 40.1) | 40.3 (31.4, 51.9) | <0.001 |
| 10. Pre-visit chart review for CRCS | 34.1 (25.7, 45.2) | 40.0 (28.7, 55.6) | 0.447 |
Significantly favor intervention.